QA: Dynavax Technologies CORP in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2020_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 208,653,000
1 IntangibleAssetsNetIncludingGoodwill 4,581,000
2 PropertyPlantAndEquipmentNet 32,022,000
3 remainder_Assets 33,812,000
4 LiabilitiesCurrent 53,047,000
5 LiabilitiesNoncurrent 217,731,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 75,343,714
9 ResearchAndDevelopmentExpense 63,044,127
10 remainder_Expenses 187,163,318
11 remainder_Revenues 31,319,568
12 remainder_NetIncome 4,225,980
13 remainder_ComprehensiveNetIncome -621,828
  yvar yval
0 Assets 279,068,000
1 Liabilities 270,778,000
2 Expenses 325,551,159
3 Revenues 31,319,568
4 StockholdersEquity 8,290,000
5 NetIncome -290,005,611
6 ComprehensiveNetIncome -290,316,525
7 BaseVar 455,782,268
8 EconomicCapitalRatiobeforeLimitedLiability -0.990
9 EconomicCapitalRatio 1.30

Edgar->Model Mapping

Feature Distribution

Change over Time